T1	Participants 42 64	after vaginal delivery
T2	Participants 163 185	after vaginal delivery
T3	Participants 226 311	patients between 22 weeks and 42 weeks of gestation with anticipated vaginal delivery
T4	Participants 794 851	a total of 1,604 patients would be required in each group
T5	Participants 861 983	A total of 848 patients were enrolled and 756 randomly assigned, 377 in the misoprostol group and 379 in the placebo group
T6	Participants 985 1073	Demographic, antepartum, and intrapartum characteristics were similar between the groups
